NEW YORK (GenomeWeb News) – MolecularHealth today announced its US clinical laboratory has been CLIA-certified.

With the certification, the Woodlands, Texas-based facility will begin offering two tests. One is a targeted gene panel of more than 500 known cancer genes, and the other offers whole-exome sequencing of the tumor genome.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.